Client News

Aspire Biopharma Holdings, Inc., (Nasdaq:ASBP) to Launch the Next Generation of Pre-Workout Performance Supplement

New product expected to set a new standard for potency and performance in the estimated $20 billon pre-workout market Desert Stream Inc., a well-established nutritional and supplement manufacturer of caffeine-based products, engaged for sourcing of ingredients, lab studies, regulatory compliance, and quality control. Single dose pre-workout supplement expected to be available in specialty retailers of […]

Updates FAQ in Response to a High Volume of Shareholder Questions

TRNR details $50M pro forma annual revenue guidance, rationale of expected Sportstech acquisition, comments on market manipulation concerns and bitcoin as a Treasury asset AUSTIN, TX / ACCESS Newswire / February 27, 2025 / Interactive Strength Inc. (Nasdaq:TRNR) (“TRNR” or the “Company”), maker of innovative specialty fitness equipment under the CLMBR and FORME brands, today […]

Interactive Strength Inc. (Nasdaq:TRNR) Quickly Receives Repeat Six-Figure CLMBR Order in Germany

Latest purchase confirms significant demand for CLMBR in Germany, quickly following on the initial order that was fulfilled in the Fall of 2024 Growing demand strengthens distributor relationship and validates TRNR’s acquisition of German market leader Sportstech Germany is the largest fitness market after the United States AUSTIN, TX / ACCESS Newswire / February 27, 2025 / Interactive […]

Interactive Strength Inc. (Nasdaq:TRNR) Launches FAQ’s About Acquisition, Business Strategy and $50M Pro Forma 2025 Guidance

Company Encourages Shareholders to Sign Up for Direct Email Updates AUSTIN, TX / ACCESS Newswire / February 26, 2025 / Interactive Strength Inc. (NASDAQ:TRNR) (“TRNR” or the “Company”), maker of innovative specialty fitness equipment under the CLMBR and FORME brands, today posted a new FAQ section on its website, noting that it was fielding many questions from interested […]

Aspire Biopharma Holdings, Inc., (NASDAQ:ASBP) Provides an Update on Lead Product Candidate: High-Dose, Sublingual Aspirin

Initial feasibility study of its soluble, Ph neutral, fast acting granular or powder drug delivery system is complete Test results support the next development step with Phase 1clinical trial expected to commence in April Provides Summary of Expected 2025 Milestones HUMACAO, PUERTO RICO AND NEW YORK, NY / ACCESS Newswire / February 25, 2025 / Aspire Biopharma Holdings, […]

Amesite (NASDAQ: AMST) Announces Enterprise Sales Growth with Automated Sales Flow for NurseMagic™ Business Customers

Automated Sales Process Has Successfully Enabled NurseMagic™ Enterprise Sales to Close within Hours of Enterprise Outreach DETROIT, Feb. 25, 2025 (GLOBE NEWSWIRE) — Amesite Inc. (NASDAQ: AMST), a pioneering technology company specializing in the development and marketing of B2C and B2B AI-driven solutions, today announced the success of its automated sales flow of its enterprise […]

Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) Announces the Execution of Securities Purchase Agreement

NEW YORK CITY, NY / ACCESS Newswire / February 20, 2025 / Aspire Biopharma, Inc. (“Aspire” or the “Company”), a developer of a multi-faceted patent-protected disruptive drug delivery mechanism technology (Nasdaq:ASBP)(Nasdaq:ASBPW), today announced that it entered into a definitive Securities Purchase Agreement (the “Agreement”) on February 19, 2025, pursuant to which the Company issued to the Buyers a […]

Digital Brands Group (OTC Pink: DBGI) Submits an Application to Uplist to a National Securities Exchange

Austin, TX, Feb. 20, 2025 (GLOBE NEWSWIRE) — Digital Brands Group, Inc. (“Digital Brands Group”) (OTC Pink: DBGI), a curated collection of luxury lifestyle, digital-first brands, announced today that it has submitted an application to list its common stock on a national securities exchange. “We believe that an uplisting to a national securities exchange is the […]

Aspire Biopharma Holdings, Inc., (Nasdaq:ASBP) Announces Public Listing on Nasdaq

The closing of the business combination with PowerUp Acquisition Corp. creates Nasdaq-listed biopharmaceutical company dedicated to developing breakthrough innovations in FDA approved drugs, nutraceuticals, and supplements Aspire has multiple product candidates in key areas of medical needs such as a fast-acting aspirin product for cardiology emergencies and pain management, a proprietary Viagra/Cialis combination product, various […]

Start Expanding
Your Shareholder Base

Let us help you connect with investors
committed to your success.